We are a CRO providing integrated, science-driven, product development services throughout the drug discovery and development process to enable life science companies to achieve their drug development goals. We have enabled many innovator, generic and consumer health companies of all sizes to file IND, NDA, ANDA, BLA and 505(b)(2) submissions in global markets allowing for successful development of important therapies and products for patients. We are committed to providing rigorous scientific expertise to ensure the highest quality and compliance. We have successfully assisted clients to advance hundreds of molecules through development to commercial launch in global markets.
We benefit greatly from having operations in both the United States and China (the two largest markets for CRO services in the world) and are well placed to capture growth opportunities in both markets. Our “Two Countries, One System” approach is integral to our commitment to high quality standards. This approach assures our customers the same quality standards, operating procedures and systems in both China and the United States, whilst also providing our customers with a detailed and highly experienced understanding of the regulations and requirements for drug discovery and development in both countries. This approach enables us to be a partner of choice for companies with multinational requirements or companies that need support for parallel submissions with the US FDA and China FDA.
